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Abstract
Clubfoot is a common birth defect that affects 135,000 newborns each year worldwide. It is
characterized by equinus deformity of one or both feet and hypoplastic calf muscles. Despite
numerous study approaches, the cause(s) remains poorly understood although a multifactorial
etiology is generally accepted. We considered the HOXA and HOXD gene clusters and insulin-like
growth factor binding protein 3 (IGFBP3) as candidate genes because of their important roles in
limb and muscle morphogenesis. Twenty SNPs from the HOXA and HOXD gene clusters and 12
SNPs in IGFBP3 were genotyped in a sample composed of nonHispanic white and Hispanic
multiplex and simplex families (discovery samples) and a second sample of nonHispanic white
simplex trios (validation sample). Four SNPs (rs6668, rs2428431, rs3801776 and rs3779456) in
the HOXA cluster demonstrated altered transmission in the discovery sample, but only rs3801776,
located in the HOXA basal promoter region, showed altered transmission in both the discovery and
validation samples (p=0.004 and p=0.028). Interestingly, HOXA9 is expressed in muscle during
development. A SNP in IGFBP3, rs13223993, also showed altered transmission (p=0.003) in the
discovery sample. Gene-gene interactions were identified between variants in HOXA, HOXD and
IGFBP3 and with previously associated SNPs in mitochondrial-mediated apoptotic genes. The
most significant interactions were found between CASP3 SNPS and variants in HOXA, HOXD and
IGFBP3. These results suggest a biologic model for clubfoot in which perturbation of HOX and
apoptotic genes together affect muscle and limb development, which may cause the downstream
failure of limb rotation into a plantar grade position.
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INTRODUCTION
Clubfoot, or talipes equinovarus (TEV), is a common birth defect which is easily recognized
and diagnosed because of the characteristic forefoot adduction, hindfoot varus and equinus,
midfoot cavus, and hypoplastic lower limb musculature [Dietz, 1985]. Isolated, or
idiopathic, cases occur in the absence of any other anomaly and/or known cause(s) [Moorthi
et al., 2005]. The birth prevalence varies among ethnic groups from 1/150-2500, with a
worldwide rate of approximately 1/1000 [Moorthi et al., 2005]. A variety of approaches
including genome scans and candidate gene testing have been used to identify the
underlying causes of complex genetic disorders. Interrogation of minimal overlapping
chromosomal deletions in syndromic clubfoot led to the identification of a group of
candidate genes, the HOXD gene cluster (UCSC Genome Bioinformatics) [Brewer et al.,
1998].
The HOX genes encode transcription factors that direct patterning of the axial skeleton and
muscle and limb development [Mark et al., 1997; McGinnis and Krumlauf, 1992]. This
family consists of 39 genes distributed in four paralogous clusters (A, B, C and D). Each of
the HOX clusters share common genomic structure and are temporally and spatially
expressed during embryogenesis. The 5’ HOXA genes are expressed in the muscles of both
the fore and hind limbs, and are involved in patterning and differentiation of muscles in
embryonic limbs and during muscle repair of adult limbs [Houghton and Rosenthal, 1999].
Mutations in HOX genes perturb normal limb development; for example, the HOXD10
956T>A/319M>K mutation causes autosomal dominant congenital vertical talus (CVT)
[Dobbs et al., 2006; Shrimpton et al., 2004].
Conditional HOXA13 knockout mice show decreased expression of insulin-like growth
factor binding protein 3 (IGFBP3) in the limbs (Dr. S. Stadler, personal communication),
which has been shown to have a role in apoptosis [Baxter and Martin, 1989]. This
observation is important because we previously reported an association between genetic
variants in Caspase genes and clubfoot [Ester et al., 2007; Heck et al., 2005].
Given the role of HOXA, HOXD and IGFBP3 in limb development, this study was
undertaken to determine whether variation in the HOXA, HOXD or IGFBP3 genes is
associated with isolated clubfoot and to further evaluate whether the 956T>A/319M>K
HOXD10 mutation causes clubfoot.
MATERIALS AND METHODS
Clubfoot study samples and sample preparation
SNPs from the HOXA and HOXD gene clusters and IGFBP3 were genotyped in the
discovery population composed of 1783 genotyped individuals from 598 singly ascertained
families as described previously [Ester et al., 2007; Heck et al., 2005]. This included a total
of 179 extended families (122 nonHispanic white (NHW) and 57 Hispanic) and 331 simplex
families (130 NHW and 201 Hispanic) and 88 trios with a positive family history (42 NHW
and 46 Hispanic). The validation population consisted of 144 NHW simplex trios.
Families in the discovery dataset were identified through a proband with clubfoot from one
of six orthopedic centers: Shriners Hospital for Children of Houston, Los Angeles and
Shreveport, Texas Scottish Rite Hospital for Children of Dallas, University of Iowa,
Department of Orthopaedics and Rehabilitation, and other collection sites, as previously
described [Ester et al., 2007; Heck et al., 2005]. Individuals from the validation population
were ascertained in the Department of Orthopedics at Washington University in St. Louis
(144 probands). All affected individuals were diagnosed with clubfoot using standardized
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clinical criteria and radiographic examination as previously described [Lochmiller et al.,
1998]. Age of ascertainment for probands generally ranged from birth to 18 years of age.
Cases were excluded if they were caused by a chromosomal abnormality or were syndromic.
Ethnicity was self-reported and informed consent was obtained.
Blood or saliva samples were collected from the affected individuals and family members.
DNA was extracted using either the Roche DNA Isolation Kit for Mammalian Blood
(Roche, Switzerland) or the Oragene Purifier for saliva (DNA Genotek, Inc., Ontario,
Canada) following the manufacturer’s protocol.
956T>A/319M>K HOXD10 mutation detection
To determine whether the 956T>A/319M>K HOXD10 mutation played a causal role in
isolated clubfoot, 494 clubfoot probands (267 NHW and 227 Hispanic) and 595 unrelated,
unaffected controls (380 NHW and 215 Hispanic) were genotyped using a custom TaqMan
assay designed using FileBuilder 3.0 (ABI, Foster City, CA). One hundred forty-four
probands ascertained later were not genotyped for this mutation. The positive control in all
assays was DNA from two individuals with CVT and the HOXD10 956T>A/319M>K
mutation.
Genotyping
SNPs were identified using NCBI and Ensembl websites and the software program
Haploview [Barrett et al., 2005]. Final SNP selection was based on heterozygosity (>0.3),
inter- and intragenic positions, coverage of the gene, and tagging ability. Using these
criteria, nine HOXA, 11 HOXD and 12 IGFBP3 SNPs were identified (Table I). SNPs were
genotyped using TaqMan® Genotyping Assays (Applied Biosystems, Foster City, CA) and
detected on a 7900 HT Sequence Detection System (Applied Biosystems, Foster City, CA).
Statistical analysis
Allele frequencies and Hardy-Weinberg Equilibrium (HWE) were calculated using SAS
(v9.1). The SNPs not in HWE (p<0.001) were identified and appropriate methods for
correction were used in the analyses. Pair-wise linkage disequilibrium values (D′ and r2)
were calculated using GOLD [Abecasis and Cookson, 2000]. Multiple methods for assessing
linkage and/or association were performed to extract the greatest amount of information
from each dataset. Parametric and non-parametric linkage analyses were conducted using
Merlin [Abecasis et al., 2002]. Two parametric models based on segregation analysis were
tested on the 179 extended families [de Andrade et al., 1998; Rebbeck et al., 1993; Wang et
al., 1988]. Model I used penetrances of 0.000, 0.020, 0.494 and 0.0, 0.008, 0.358 while
model II used 0.0, 0.002, 0.067 and of 0.0, 0.008, 0.358 for males and females, respectively.
The rsq option (rsq=0.16) of Merlin was used to remove the effects of LD.
Association in the Presence of Linkage (APL) was used to analyze association because this
program incorporates data even when a parental genotype is missing [Chung et al., 2006].
The APL software was also used to assess transmission of 2-SNP haplotypes within a gene
or gene clusters. Generalized Estimating Equations (GEE) were used to detect gene-gene
interactions for all SNPs [Hancock et al., 2007].
Identification of transcription factor binding sites
In silico analyses of all the over-transmitted SNP sequences in regulatory regions were
performed using three online algorithms: Alibaba2, Patch and Transcription Element Search
Software (TESS) [Grabe 2002; Matys et al., 2006; Schug 2003]. Ancestral and alternate
(www.ncbi.nlm.nih.gov/) allele sequences were inputted into the program and the output
was compared.
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This study was reviewed and approved by the Committee for the Protection of Human
Subjects at the University of Texas Heath Science Center (HSC-MS-04-239).
RESULTS
The 956T>A/319M>K HOXD10 mutation was not detected in any of the 494 probands (267
NHW and 227 Hispanic) or the 595 unrelated controls (380 NHW and 215 Hispanic). This
excluded a maximum carrier frequency 0.005 with over 80% power in both ethnic groups.
We next interrogated the HOXA and HOXD gene clusters and IGFBP3 in the discovery
population. Only rs10255707 was not in HWE (p<0.0001) in either ethnic group (data not
shown). Comparisons of SNP allele frequencies between NHW and Hispanics detected
significant differences in the majority of SNPs in all genes even after Bonferroni correction
(p<0.001) (Table I). Therefore, the data were stratified by ethnicity and examined
separately. The data was combined across ethnicities for SNPs showing no differences in
frequency.
Affected individuals had slightly higher levels of linkage disequilibrium (LD) than
unaffected individuals in both ethnic groups (Supplemental Tables I–IV). Parametric and
nonparametric multipoint linkage analysis detected suggestive evidence (LOD>1.5) for
linkage to IGFBP3 in the Hispanic subset (Table II). No evidence of linkage was found for
HOXA or HOXD with clubfoot (data not shown).
The APL analysis in the discovery population found significant evidence for association
with SNPs in the HOXA and HOXD gene clusters and IGFBP3 (Table III). The strongest
associations were seen for rs3801776 in the combined discovery NHW multiplex and
simplex group (p=0.004) and when stratified by family history, and for rs13223993 in
IGFBP3 in the simplex families (p=0.003) (Table III). Additionally, a strong association for
rs6749771 in HOXD was found in the NHW simplex families (p=0.009). In contrast, in the
Hispanic sample, the strongest association was with rs2428431 (p=0.008) in the HOXA gene
cluster, with no evidence for association found with SNPs in HOXD or IGFBP3.
Interestingly, when the ethnicities were combined, rs2428431 in HOXA was still significant
(Table III).
Significantly over-transmitted haplotypes for HOXA and HOXD were seen in NHW and
only for HOXA in Hispanics (Table IV and Supplemental Tables 5 – 7). These haplotypes
primarily involve the SNPs identified in the single SNP association analyses (Table III).
Among the NHW, the most significant haplotype for HOXA involved rs3801776 (HOXA9)
and rs1859164 (HOXA10), which were located in the 5’ region of the HOXA cluster; both
HOXA9 and HOXA10 are expressed during limb development (Table IV). In Hispanics,
haplotypes involving rs2428431 or rs2428431 (HOXA) were also over-transmitted
(0.006≤p≤0.009, Table IV and Supplemental Table V).
There was no evidence for interactions between HOXA and HOXD in the discovery NHW
group. However for the discovery Hispanic dataset, there was evidence for interactions
between HOXA and HOXD for rs6758117/ rs2428431 and rs1867863/ rs3801776 (p=0.006
and p=0.007, respectively, data not shown). Interactions were found in the discovery sample
for SNPs in HOXA/HOXD and IGFBP3 (Table V). The strongest interaction was between
rs3801776 (HOXA) and rs13223993 (IGFBP3) in the NHW subset (p=0.0001, Table V and
Supplemental Table IX and X). Interestingly, significant HOXA interactions were found for
rs13223993 and 5’ HOX SNPs expressed in limb development in both NHW and Hispanic
groups.
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All SNPs were then tested in the validation dataset. There was evidence for association with
rs3801776 in HOXA (p=0.028). Analysis of 2-SNP haplotypes in this sample identified
seven HOXA haplotypes with altered transmission, none of which were identified in the
discovery population (Table IV and Supplemental Table VIII). The most significant
haplotypes in the validation population were rs3779456/ rs3807598 (p=0.007) and
rs1859164/ rs3807598 (p=0.0003, Supplemental Table VIII).
There was no evidence for an interaction between SNPs in HOXA and HOXD in the
validation dataset (data not shown). In contrast, multiple interactions between SNPs in
HOXA and IGFBP3 and HOXD and IGFBP3 were identified in the validation population;
the majority of these interactions involved SNPs in HOXD and SNPs in IGFBP3 (Table VI
and Supplemental Table XI) but are different from those found in the discovery population
(Supplemental Tables IX and XI).
We have previously reported an association of variants in mitochondrial-mediated apoptotic
genes with clubfoot in our discovery dataset [Ester et al., 2007]. Since the genes in the
current study were involved in both apoptosis and limb formation, we combined the data
from the previous study with that of the current study to evaluate potential gene-gene
interactions in the discovery sample. The results are presented in Table VI and Supplemental
Tables XII and XIII. While multiple interactions between HOX and IGFBP3 genes with
mitochondrial-mediated genes were found in both ethnicities, none of these interactions
having a p<0.01 were the same in both ethnicities. There was, however, strong evidence for
interaction between SNPs in HOXA and HOXD and SNPs in both CASP3 and Bid in NHW
(Table VIA). The strongest interaction was between a SNP in CASP3 and one in IGFBP3 in
NHW (Table VIA). In Hispanics, the strongest interactions were between SNPs in CASP3
and HOXD; two SNPs in IGFBP3 interacted with two SNPs in Apaf1 (Table VIB).
Because the HOX clusters were controlled by many different regulatory factors, SNPs in the
intergenic regions of the clusters may be in DNA enhancer or suppressor binding sites.
Therefore, each of the over-transmitted SNPs in these regions was assessed using three
transcription factor binding site prediction algorithms and the results are shown in Table
VII. rs2428431 was predicted to change ancestral binding sites by all three programs, but
predicted binding factors differed (Table VII). In contrast, the ancestral rs3801776 allele
was not identified as a potential binding site by any of the programs, while the alternative
allele was identified as a potential binding site by two of the programs (Table VII).
However, rs6749771 was not predicted to change transcription factor binding sites (data not
shown).
DISCUSSION
This study was undertaken to assess the roles of limb and muscle morphogenesis genes in
clubfoot. The 956T>A/319M>K HOXD10 mutation that causes syndromic vertical talus was
not found in any cases or controls. This result confirms previous findings and provides
further evidence that this mutation does not cause isolated clubfoot [Gurnett et al., 2007].
Next, we evaluated whether variants in the HOXA and HOXD gene clusters and IGFBP3 are
associated with clubfoot in our family-based dataset. This was accomplished by genotyping
SNPs spanning the HOXA, HOXD and IGFBP3 genes first in our discovery sample with
follow-up in our validation sample. Located 3’ of the HOXD cluster, SNP1 showed altered
transmission and may regulate expression of genes within the cluster. In the HOXA gene
cluster, rs2428431 and rs3801776 were significantly over-transmitted. In intron 1 of
HOXA2, rs2428431 is changes predicted DNA binding sites (Table VII). The HOXA2 gene
is not expressed in the limb, but we cannot exclude the possibility that rs2428431 may
regulate expression levels of other upstream 5’ HOXA genes or is in linkage disequilibrium
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with SNPs that do [Sasaki et al., 2007; Tarchini and Duboule, 2006]. Located in the HOXA9
basal promoter region, rs3801776 showed altered transmission in NHW in the discovery
sample and was confirmed in the validation group. Furthermore, pair-wise haplotypes
involving rs3801776 were significantly over-transmitted and gene-gene interactions
involving this SNP were found. The HOXA9 gene is expressed in both the proximal and
distal limb and the variant allele is predicted to introduce a novel DNA binding site (Table
VII). This change could alter expression levels of HOXA9 and affect normal limb or muscle
development. Future studies are aimed at determining whether rs3801776 is functional or if
it is in linkage disequilibrium with a functional change.
Three SNPs (rs3793345, rs2471551 and rs13223993) in IGFBP3 were over-transmitted in
the discovery sample. Interestingly, rs3793345 and rs2471551 are located in a potential
enhancer/regulatory region in intron 1 and the SNP variants are predicted to change DNA
binding sites (data not shown). Located in the 3’ UTR of IGFBP3, rs13223993 showed the
most significant results. Previously, SNPs in 3’ UTRs are have been shown to regulate
protein expression through microRNAs or proteins that can stabilize or destabilize the half-
life of mRNA [Wickens et al., 2002]. Additionally, rs2132572 and rs2854747 in IGFBP3
were only marginally significant in the validation group but not the discovery dataset and do
not change DNA binding sites (data not shown). Functional studies are necessary to further
assess these SNP variants that could potentially change DNA binding and protein expression
and thus affect limb development [Wolters and Wijmenga, 2008].
Because clubfoot is a complex disorder, multiple genes are likely involved although a major
gene effect cannot be excluded. This allows us to postulate a model in which multiple genes
interact and together are necessary but individually are not sufficient to cause disease.
Moreover, we suggest that multiple variants within a gene may cause perturbation of gene
function, rather than a single common variant, and thus any one SNP may not demonstrate
significant evidence (very small p-values) for association. Therefore association within a
gene is considered replication, even if different SNPs are over-transmitted in the two
datasets. This standard of replication also was applied to gene-gene interactions. Here, we
find that rs3801776 is associated with clubfoot, and in addition, we find that variation in
apoptotic genes interact with several variants in HOXA and HOXD. These results are
consistent with a recent study demonstrating that apoptosis is important for muscle
morphogenesis [Rodriguez-Guzman et al., 2007].
Apoptosis is associated with interdigital removal of excess skin; however, it has recently
been shown to play a far more subtle role in later limb development by shaping muscle and
tendons [Rodriguez-Guzman et al., 2007]. Specifically, CASP3 has been shown to modulate
apoptosis in later muscle and tendon development. While we did not find a strong
association with CASP3 and clubfoot alone [Ester et al., 2007], we found evidence for
interactions between CASP3 and variants in HOX genes and IGFBP3. This implies that
individual variation in CASP3 may not be sufficient to cause clubfoot but that the interaction
with genes in other limb and muscle developmental pathways, such as HOXA and HOXD,
are necessary in order to disrupt the developmental process. The interactions observed
between the many mitochondrial-mediated apoptotic genes and HOXA and HOXD genes
suggest that there may be a common mechanism controlling these two pathways.
Perturbations of this regulatory pathway may also contribute to clubfoot.
The goal of this study was to identify high-risk haplotypes that would contribute to clubfoot.
The first step in this process is to identify genetic variants that are associated with clubfoot
and to determine whether they interact. The results of our studies suggest a model for
clubfoot that is shown in Figure 1 and includes the interactions between different genes. It is
possible that environmental exposures alone can cause clubfoot, but it is more likely that an
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individual’s genotype confers an increased susceptibility to these exposures. This model
further suggests that severity of phenotype may relate to the number of genetic variants and/
or genetic pathways affected by the variants (Fig. 1). In this study, we found evidence for an
association between a basal promoter SNP in HOXA9 and clubfoot, and provide further
evidence that interactions between genes involved in limb development play a role in
clubfoot.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
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Table IV
Overtransmitted HoxA and HoxD haplotypes in discovery samplea,b
A. nonHispanic White
Haplotype p-value
HoxD
SNP1/SNP2 0.007
SNP1/SNP6 0.007
SNP1/SNP7 0.006
HoxA SNP16/SNP18 0.004
B. Hispanic
Haplotype p-value
HoxA
SNP14/SNP15 0.009
SNP14/SNP19 0.006
SNP16/SNP12 0.006
a
Haplotypes with p<0.01 shown,
b
p-values uncorrected for multiple testing
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Table VI
Gene-gene interactions for Hox IGFBP3 and mitochondrial-mediated apoptotic variants in discovery dataseta,b
A. nonHispanic White
Gene 1 SNP 1 Gene 2 SNP 2 p-value
Casp3 rs1049216
HoxD
rs6749771 (SNP1) 0.002
Casp3 rs1405937 rs6749771 (SNP1) 0.005
Casp3 rs1049253 rs2592394 (SNP7) 0.001
Casp3 rs1049216 rs2592394 (SNP7) 0.008
Bid rs8919 rs6758117 (SNP11) 0.007
Casp3 rs2720378
HoxA
rs6668 (SNP13) 0.004
Casp3 rs1049216 rs1859164 (SNP18) 0.004
Casp3 rs2720378 rs1859164 (SNP18) 0.004
Casp10 rs3900115 rs3779456 (SNP17) 0.008
Bid rs181405 rs3779456 (SNP17) 0.001
Bid rs181405 rs1859164 (SNP18) 0.005
Apaf1 rs2132572
IGFBP3
rs2132572 (SNP22) 0.008
Casp3 rs1049210 rs2132572 (SNP22) <.0001
Casp3 rs1049210 rs2854744 (SNP23) 0.006
Casp3 rs1049210 rs10255707 (SNP29) 0.002
Casp3 rs1049210 rs2854746 (SNP24) 0.005
Casp8 rs3769825 rs10255707 (SNP29) 0.003
Casp10 rs3900115 rs2854747 (SNP25) 0.008
B. Hispanic
Gene 1 SNP 1 Gene 2 SNP 2 p-value
Casp3 rs4647602
HoxD
rs1318778 (SNP3) 0.0005
Casp3 rs4647602 rs2113563 (SNP6) 0.009
Casp3 rs2696057 rs741610 (SNP9) 0.008
Bcl2 rs1564483
HoxA
rs3801776 (SNP16) 0.002
Casp9 rs4233533 rs3779456 (SNP17) 0.001
Apaf1 rs1866477 rs6968828 (SNP19) 0.009
Apaf1 rs2278361
IGFBP3
rs2132571 (SNP21) 0.007
Apaf1 rs2278361 rs2453839 (SNP30) 0.002
Apaf1 rs7968661 rs2453839 (SNP30) 0.006
a
only p<0.01 shown,
b
p-values uncorrected for multiple testing
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